Cargando…
Progestins and the endometrium in patients receiving tamoxifen
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363044/ https://www.ncbi.nlm.nih.gov/pubmed/10362126 http://dx.doi.org/10.1038/sj.bjc.6690473 |
Ejemplares similares
-
Assessment of thickened endometrium in tamoxifen therapy
por: Korkmazer, Engin, et al.
Publicado: (2014) -
Tamoxifen induction of angiogenic factor expression in endometrium
por: Hague, S, et al.
Publicado: (2002) -
K-ras mutation in the endometrium of tamoxifen-treated breast cancer patients, with a comparison of tamoxifen and toremifene
por: Hachisuga, T, et al.
Publicado: (2005) -
Comparative evaluation of raloxifene versus estrogen: Progestin on symptomatology, endometrium, and lipid profile in postmenopausal women
por: Dogiparthi, Anuradha, et al.
Publicado: (2010) -
Intercellular adhesion molecule-1 expression in human endometrium: implications for long term progestin only contraception
por: Schatz, Frederick, et al.
Publicado: (2006)